Effect of periodontitis on cardiovascular manifestations in marfan syndrome: Critical common role of TGF-β

International Heart Journal

Volumn 56, Issue 2, 2015, Pages 121-124

  Suzuki, Jun Ichi ^a   Aoyama, Norio ^b   Izumi, Yuichi ^b   Isobe, Mitsuaki ^b   Komuro, Issei ^a   Hirata, Yasunobu ^c  

^a UNIVERSITY OF TOKYO   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c TOKYO TEISHIN HOSPITAL   (Japan)

Author keywords

Bacteria; Cardiovascular complications; Connective tissue disorder; Matrix metalloproteinases; Oral diseases

Indexed keywords

CYTOKINE; FIBRILLIN 1; MATRIX METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR BETA;

BLOOD LEVEL; CARDIOVASCULAR DISEASE; DISEASE ASSOCIATION; GINGIVITIS; HUMAN; INCIDENCE; MARFAN SYNDROME; PATHOPHYSIOLOGY; PERIODONTITIS; PRIORITY JOURNAL; REVIEW; SALIVA LEVEL; BLOOD; COMPLICATION;

HUMANS; MARFAN SYNDROME; PERIODONTITIS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84929939275     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.14-247     Document Type: Review

References (43)

1. Dietz HC, Cutting GR, Pyeritz RE, et al. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 1991; 352: 337-9.
2. Maslen CL, Corson GM, Maddox BK, Glanville RW, Sakai LY. Partial sequence of a candidate gene for the Marfan syndrome. Nature 1991; 352: 334-7.
3. Sakai LY, Keene DR, Engvall E. Fibrillin, a new 350-kD glyco-protein, is a component of extracellular microfibrils. J Cell Biol 1986; 103: 2499-509.
4. Rybczynski M, Bernhardt AM, Rehder U, et al. The spectrum of syndromes and manifestations in individuals screened for suspect-ed Marfan syndrome. Am J Med Genet A 2008; 146A: 3157-66.
5. Ammash NM, Sundt TM, Connolly HM. Marfan syndrome-diag-nosis and management. Curr Probl Cardiol 2008; 33: 7-39. (Re-view).
6. Miyairi T, Miyata H, Taketani T, et al; Japan Adult Cardiovascular Database Organization. Risk model of cardiovascular surgery in 845 Marfan patients using the Japan adult cardiovascular surgery database. Int Heart J 2013; 54: 401-4.
7. Loeys BL, Dietz HC, Braverman AC, et al. The revised Ghent no-sology for the Marfan syndrome. J Med Genet 2010; 47: 476-85.
8. Westling L, Mohlin B, Bresin A. Craniofacial manifestations in the Marfan syndrome: palatal dimensions and a comparative ce-phalometric analysis. J Craniofac Genet Dev Biol 1998; 18: 211-8.
9. Choi BK, Jung JH, Suh HY, et al. Activation of matrix metallopro-teinase-2 by a novel oral spirochetal species Treponema lecithino-lyticum. J Periodontol 2001; 72: 1594-600.
10. Salvi GE, Lang NP. Host response modulation in the management of periodontal diseases. J Clin Periodontol 2005; 32: 108-29. (Re-view).
11. Ashley RA. Clinical trials of a matrix metalloproteinase inhibitor in human periodontal disease. SDD Clinical Research Team. Ann N Y Acad Sci 1999; 878: 335-46.
12. Reis C, DA Costa AV, Guimarães JT, et al. Clinical improvement following therapy for periodontitis: Association with a decrease in IL-1 and IL-6. Exp Ther Med 2014; 8: 323-7.
13. Mattila KJ, Nieminen MS, Valtonen VV, et al. Association be-tween dental health and acute myocardial infarction. BMJ 1989; 298: 779-81.
14. Sakurai K, Wang D, Suzuki J, et al. High incidence of actinobacil-lus actinomycetemcomitans infection in acute coronary syndrome. Int Heart J 2007; 48: 663-75.
15. Mendez MV, Scott T, LaMorte W, Vokonas P, Menzoian JO, Gar-cia R. An association between periodontal disease and peripheral vascular disease. Am J Surg 1998; 176: 153-7.
16. Kurihara N, Inoue Y, Iwai T, Umeda M, Huang Y, Ishikawa I. De-tection and localization of periodontopathic bacteria in abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 2004; 28: 553-8.
17. Paraskevas KI, Mikhailidis DP, Giannoukas AD. Periodontitis and abdominal aortic aneurysms: a random association or a pathoge-netic link? Int Angiol 2009; 28: 431-3. (Review).
18. Delbosc S, Alsac JM, Journe C, et al. Porphyromonas gingivalis participates in pathogenesis of human abdominal aortic aneurysm by neutrophil activation. Proof of concept in rats. PLoS One 2011; 6: e18679.
19. Aoyama N, Suzuki J, Wang D, et al. Porphyromonas gingivalis promotes murine abdominal aortic aneurysms via matrix metallo-proteinase-2 induction. J Periodontal Res 2011; 46: 176-83.
20. Aoyama N, Suzuki JI, Ogawa M, et al. Clarithromycin suppresses the periodontal bacteria-accelerated abdominal aortic aneurysms in mice. J Periodontal Res 2012; 47: 463-9.
21. Aoyama N, Suzuki J, Ogawa M, et al. Toll-like receptor-2 plays a fundamental role in periodontal bacteria-accelerated abdominal aortic aneurysms. Circ J 2013; 77: 1565-73.
22. Suzuki J, Aoyama N, Aoki M, et al. High incidence of periodontitis in Japanese patients with abdominal aortic aneurysm. Int Heart J 2014; 55: 268-70.
23. Suzuki J, Aoyama N, Aoki M, et al. Incidence of periodontitis in Japanese patients with cardiovascular diseases: a comparison betweenabdominal aortic aneurysm and arrhythmia. Heart Vessels(in press).
24. Ogawa N, Imai Y, Nishimura H, et al. Circulating transforming growth factor β-1 level in Japanese patients with Marfan syn-drome. Int Heart J 2013; 54: 23-6.
25. Chaudhry SS, Cain SA, Morgan A, Dallas SL, Shuttleworth CA, Kielty CM. Fibrillin-1 regulates the bioavailability of TGFbeta1. J Cell Biol 2007; 176: 355-67. 26. Huang F, Chen YG. Regulation of TGF-β receptor activity. Cell Biosci 2012; 2: 9.
26. Huang F, Chen YG. Regulation of TGF-β receptor activity. Cell Biosci 2012; 2: 9.
27. Dietz HC. 2006 Curt Stern Award Address. Marfan syndrome: from molecules to medicines. Am J Hum Genet 2007; 81: 662-7.
28. Wang Y, Krishna S, Walker PJ, Norman P, Golledge J. Transforming growth factor-β and abdominal aortic aneurysms. Cardiovasc Pathol 2013; 22: 126-32. (Review).
29. Jones JA, Spinale FG, Ikonomidis JS. Transforming growth factor-beta signaling in thoracic aortic aneurysm development: a paradox in pathogenesis. J Vasc Res 2009; 46: 119-37. (Review).
30. Khan R, Sheppard R. Fibrosis in heart disease: understanding the role of transforming growth factor-beta in cardiomyopathy, valvu-lar disease and arrhythmia. Immunology 2006; 118: 10-24. (Re-view).
31. Khalaf H, Lönn J, Bengtsson T. Cytokines and chemokines are differentially expressed in patients with periodontitis: possible role for TGF-β1 as a marker for disease progression. Cytokine 2014; 67: 29-35.
32. Zhang B, Elmabsout AA, Khalaf H, et al. The periodontal patho-gen Porphyromonas gingivalis changes the gene expression in vascular smooth muscle cells involving the TGFbeta/Notch signal-ling pathway and increased cell proliferation. BMC Genomics 2013; 14: 770.
33. Matsuda N, Lin WL, Kumar NM, Cho MI, Genco RJ. Mitogenic, chemotactic, and synthetic responses of rat periodontal ligament fibroblastic cells to polypeptide growth factors in vitro. J Periodontol 1992; 63: 515-25.
34. Overall CM, Wrana JL, Sodek J. Independent regulation of colla-genase, 72-kDa progelatinase, and metalloendoproteinase inhibi- tor expression in human fibroblasts by transforming growth factor-beta. J Biol Chem 1989; 264: 1860-9.
35. Ohshima M, Yamaguchi Y, Matsumoto N, et al. TGF-β signaling in gingival fibroblast–epithelial interaction. J Dent Res 2010; 89: 1315-21.
36. Tervahartiala T, Pirilä E, Ceponis A, et al. The in vivo expression of the collagenolytic matrix metalloproteinases (MMP-2, -8, -13, and -14) and matrilysin (MMP-7) in adult and localized juvenile periodontitis. J Dent Res 2000; 79: 1969-77.
37. Okada H, Murakami S. Cytokine expression in periodontal health and disease. Crit Rev Oral Biol Med 1998; 9: 248-66. (Review).
38. Neptune ER, Frischmeyer PA, Arking DE, et al. Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syn-drome. Nat Genet 2003; 33: 407-11.
39. Gallo EM, Loch DC, Habashi JP, et al. Angiotensin II-dependent TGF-β signaling contributes to Loeys-Dietz syndrome vascular pathogenesis. J Clin Invest 2014; 124: 448-60.
40. De Coster PJ, Martens LC, De Paepe A. Oral manifestations of patients with Marfan syndrome: a case-control study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002; 93: 564-72.
41. Judge DP, Dietz HC. Therapy of Marfan syndrome. Annu Rev Med 2008; 59: 43-59. (Review).
42. Suzuki JI, Imai Y, Aoki M, et al. High incidence and severity of periodontitis in patients with Marfan syndrome in Japan. Heart Vessels (in press).
43. Suzuki J, Imai Y, Aoki M, et al. Periodontitis in cardiovascular disease patients with or without Marfan syndrome --a possible role of Prevotella intermedia. PLoS One 2014; 9: e95521.